HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chris J L M Meijer Selected Research

Epitopes

5/2006Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells.
7/2005Identification of a potential human telomerase reverse transcriptase-derived, HLA-A1-restricted cytotoxic T-lymphocyte epitope.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chris J L M Meijer Research Topics

Disease

65Neoplasms (Cancer)
11/2021 - 01/2002
55Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2021 - 03/2002
32Infections
01/2021 - 04/2002
27Papillomavirus Infections
01/2021 - 03/2002
23Carcinoma (Carcinomatosis)
01/2018 - 03/2002
21Uterine Cervical Dysplasia
01/2022 - 11/2002
15Carcinogenesis
07/2016 - 10/2002
10Lymphoma (Lymphomas)
04/2010 - 01/2002
8B-Cell Lymphoma (Lymphoma, B Cell)
01/2008 - 03/2002
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2010 - 03/2002
4Lung Neoplasms (Lung Cancer)
10/2011 - 05/2003
3Persistent Infection
01/2019 - 05/2015
3Atypical Squamous Cells of the Cervix
11/2015 - 08/2006
3Squamous Cell Carcinoma of Head and Neck
06/2013 - 07/2004
3Melanoma (Melanoma, Malignant)
08/2008 - 09/2005
3Adenocarcinoma
03/2006 - 03/2002
3Nasopharyngeal Carcinoma
07/2005 - 12/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2005 - 11/2002
3Stomach Neoplasms (Stomach Cancer)
03/2004 - 08/2002
3Hodgkin Disease (Hodgkin's Disease)
10/2003 - 01/2002
2Condylomata Acuminata (Genital Wart)
01/2018 - 01/2005
2Warts (Wart)
01/2016 - 12/2005
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2015 - 06/2002
2Breast Neoplasms (Breast Cancer)
06/2013 - 06/2008
2Head and Neck Neoplasms (Head and Neck Cancer)
06/2013 - 12/2007
2Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2010 - 01/2002
2Squamous Intraepithelial Lesions
08/2008 - 09/2002
2Necrosis
01/2007 - 08/2006
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2006 - 08/2004
2Leukemia
08/2004 - 08/2004
2Atherosclerosis
06/2004 - 10/2003
2Inflammation (Inflammations)
10/2003 - 07/2003
2Epstein-Barr Virus Infections
10/2003 - 01/2003
2Infarction (Infarctions)
07/2003 - 11/2002
2Myocardial Infarction
11/2002 - 01/2002
1Reinfection
01/2021
1Anus Neoplasms (Anal Cancer)
01/2019
1Breakthrough Infections
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2016
1Metaplasia
05/2014

Drug/Important Bio-Agent (IBA)

47DNA (Deoxyribonucleic Acid)IBA
08/2021 - 03/2002
32VaccinesIBA
01/2019 - 08/2004
19Proteins (Proteins, Gene)FDA Link
10/2020 - 03/2002
12AntibodiesIBA
10/2014 - 03/2002
12Messenger RNA (mRNA)IBA
06/2013 - 06/2002
11Papillomavirus Vaccines (HPV Vaccines)IBA
01/2019 - 08/2003
9Biomarkers (Surrogate Marker)IBA
11/2021 - 06/2005
8ParaffinIBA
04/2013 - 08/2002
6MicroRNAs (MicroRNA)IBA
01/2019 - 06/2010
6Formaldehyde (Formol)FDA Link
04/2013 - 11/2005
6Telomerase (Telomerase Reverse Transcriptase)IBA
08/2010 - 07/2003
5CaspasesIBA
07/2005 - 03/2002
4Oncogene Proteins (Oncogene Protein)IBA
09/2011 - 10/2002
4EnzymesIBA
02/2010 - 08/2002
4Biological ProductsIBA
11/2009 - 05/2003
4Granzymes (Granzyme)IBA
08/2008 - 01/2002
4AntigensIBA
06/2008 - 08/2004
4RNA (Ribonucleic Acid)IBA
02/2004 - 08/2002
3Acetic Acid (Vinegar)FDA LinkGeneric
11/2015 - 01/2005
3Transcription Factors (Transcription Factor)IBA
11/2014 - 09/2006
3Cyclin-Dependent Kinase Inhibitor p16IBA
04/2013 - 09/2003
3cyclo(Arg-Pro) (CI 4)IBA
08/2008 - 07/2006
3Interleukin-12 (IL 12)IBA
06/2008 - 11/2005
3Caspase 9IBA
01/2008 - 04/2005
3CytokinesIBA
01/2007 - 01/2006
3Oral ContraceptivesIBA
11/2006 - 03/2002
3Peptides (Polypeptides)IBA
05/2006 - 07/2005
3Caspase 3 (Caspase-3)IBA
07/2005 - 03/2002
2Combined VaccinesIBA
01/2019 - 01/2015
2A-Form DNA (A-DNA)IBA
01/2018 - 05/2014
2Immunoglobulin G (IgG)IBA
02/2013 - 01/2013
2Myelin and Lymphocyte-Associated Proteolipid ProteinsIBA
11/2011 - 11/2009
2Interleukin-2 (IL2)IBA
10/2007 - 01/2007
2AutoantigensIBA
10/2007 - 11/2005
2Interleukin-4 (Interleukin 4)IBA
01/2007 - 03/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007 - 03/2006
2NucleolinIBA
08/2006 - 10/2002
2EpitopesIBA
05/2006 - 07/2005
2Protease Inhibitors (Protease Inhibitor)IBA
09/2005 - 01/2002
2Caspase 8 (Caspase-8)IBA
04/2005 - 04/2005
2Epstein-Barr virus encoded RNA 1IBA
02/2004 - 08/2002
2Secretory Phospholipases A2IBA
10/2003 - 01/2002
1ST6GalNAc V brain-specific GD1alpha synthaseIBA
10/2018
1hydrogen sulfite (bisulfite)IBA
07/2016
1Bortezomib (Velcade)FDA Link
09/2015
1Neoplasm Antigens (Tumor Antigens)IBA
06/2013
1SurvivinIBA
06/2013
1human MIRN203 microRNAIBA
02/2013
1human MIRN149 microRNAIBA
02/2013
1Viral DNAIBA
01/2013

Therapy/Procedure

8Aftercare (After-Treatment)
01/2022 - 11/2002
8Therapeutics
01/2016 - 03/2002
8Drug Therapy (Chemotherapy)
04/2010 - 07/2002
6Immunotherapy
01/2016 - 02/2005
4Male Circumcision
01/2021 - 04/2002
2Secondary Prevention
11/2012 - 02/2009
2Intrauterine Devices (Intrauterine Device)
10/2011 - 03/2006
2Condoms (Condom)
12/2003 - 12/2003
1Lasers (Laser)
11/2018
1Hysterectomy
12/2017